Inventor · disambiguated record
Jennifer R. Cochran
Also filed as: COCHRAN JENNIFER R
41 granted patents·35 pending applications·206 citations·filing 2004–2024
98Inventor score
Files withUNIV LELAND STANFORD JUNIOR52COCHRAN JENNIFER R7XCELLA BIOSCIENCES INC5Nodus Therapeutics3GIACCIA AMATO J2
Top patents by PatentIndex Score
76 records- 0195US11498952B2Fusion proteins comprising an engineered knottin peptide and uses thereofUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Nov 15, 2022·4 cites·3 claims
- 0295US10350266B2Method of treating cancer with a multiple integrin binding Fc fusion proteinNodus Therapeutics·Filed 2017·Granted Jul 16, 2019·18 cites·17 claims
- 0394US12240882B2Fusion proteins comprising an engineered knottin peptide and uses thereofUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Mar 4, 2025·2 cites·14 claims
- 0494US10526600B2Micro-screening apparatus, process, and productsUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jan 7, 2020·6 cites·7 claims
- 0594US8536301B2Engineered integrin binding peptidesCOCHRAN JENNIFER R·Filed 2009·Granted Sep 17, 2013·24 cites·10 claims
- 0693US10166273B2Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion proteinMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Jan 1, 2019·19 cites·20 claims
- 0792US11085039B2Methods and systems for screening using microcapillary arraysXCELLA BIOSCIENCES INC·Filed 2016·Granted Aug 10, 2021·5 cites·28 claims
- 0892US10370653B2Micro-screening apparatus, process, and productsUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Aug 6, 2019·5 cites·19 claims
- 0991US10227583B2Methods and systems for screening using microcapillary arraysXCELLA BIOSCIENCES INC·Filed 2017·Granted Mar 12, 2019·6 cites·26 claims
- 1091US8618254B2Inhibition of AXL signaling in anti-metastatic therapyGIACCIA AMATO J·Filed 2012·Granted Dec 31, 2013·25 cites·8 claims
- 1190US11473081B2Methods and systems for screening using microcapillary arraysXCELLA BIOSCIENCES INC·Filed 2017·Granted Oct 18, 2022·4 cites·27 claims
- 1288US11466063B2Conjugated knottin mini-proteins containing non-natural amino acidsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Oct 11, 2022·2 cites·20 claims
- 1388US9074192B2Inhibition of AXL signaling in anti-metastatic therapyGIACCIA AMATO J·Filed 2012·Granted Jul 7, 2015·7 cites·7 claims
- 1488US8247531B2Mutant epidermal growth factor polypeptides, nucleic acids, and uses thereforCOCHRAN JENNIFER R·Filed 2007·Granted Aug 21, 2012·12 cites·11 claims
- 1587US11096989B2Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion proteinUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Aug 24, 2021·3 cites·31 claims
- 1687US9913878B2Engineered integrin binding peptide compositionsUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Mar 13, 2018·2 cites·18 claims
- 1785US10888603B2Methods of treating cancer cells expressing tumor-associated integrinsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Jan 12, 2021·4 cites·35 claims
- 1885US10603358B2Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulatorNodus Therapeutics·Filed 2018·Granted Mar 31, 2020·2 cites·19 claims
- 1985US10407477B2Conjugated knottin mini-proteins containing non-natural amino acidsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 10, 2019·4 cites·16 claims
- 2085US9587001B2Conjugated knottin mini-proteins containing non-natural amino acidsUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Mar 7, 2017·7 cites·22 claims
- 2185US9556248B2Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonistsCOCHRAN JENNIFER R·Filed 2011·Granted Jan 31, 2017·5 cites·20 claims
- 2284US9265845B2Imaging methods using engineered integrin binding peptidesUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Feb 23, 2016·3 cites·22 claims
- 2384US8778888B2Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of useCOCHRAN JENNIFER R·Filed 2010·Granted Jul 15, 2014·4 cites·20 claims
- 2483US9879061B2Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosisUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Jan 30, 2018·4 cites·4 claims
- 2583US2024352444A1Methods and systems for screening using microcapillary arraysXCELLA BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2682US10844106B2Fusion proteins comprising an engineered knottin peptide and uses thereofCOCHRAN JENNIFER R·Filed 2011·Granted Nov 24, 2020·3 cites·24 claims
- 2782US8741839B2Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrinCOCHRAN JENNIFER R·Filed 2010·Granted Jun 3, 2014·5 cites·12 claims
- 2881US12024705B2Methods and systems for screening using microcapillary arraysXCELLA BIOSCIENCES INC·Filed 2022·Granted Jul 2, 2024·0 cites·28 claims
- 2980US10765625B2Knottin-drug conjugates and methods of using the sameUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 8, 2020·2 cites·33 claims
- 3080US9441026B2Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Sep 13, 2016·3 cites·4 claims
- 3179US11136563B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Oct 5, 2021·1 cites·6 claims
- 3279US9266947B2Inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Feb 23, 2016·4 cites·6 claims
- 3378US9822347B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Nov 21, 2017·3 cites·3 claims
- 3478US9234021B2Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jan 12, 2016·2 cites·2 claims
- 3573US11446356B2Peptides and related compositions and methodsUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 20, 2022·0 cites·17 claims
- 3673US9505822B2Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Nov 29, 2016·1 cites·9 claims
- 3769US2022220458A1Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic TherapyUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 3868US8865864B2Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and useCOCHRAN JENNIFER R·Filed 2012·Granted Oct 21, 2014·1 cites·1 claims
- 3968US8329826B2Surface modification of interpenetrating polymer networksHARTMANN LAURA·Filed 2009·Granted Dec 11, 2012·3 cites·3 claims
- 4068US2022193197A1Synergistic tumor treatment with il-2 and integrin-binding-fc fusion proteinUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4167US2018303902A1Engineered integrin binding peptide compositionsUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 4266US2022033453A1Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonistsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4365US9963495B2Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigenUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted May 8, 2018·1 cites·21 claims
- 4465US2022213171A1Ciliary Neurotrophic Factor Receptor Ligand-Binding Agents and Methods of Using the SameUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4564US2025198990A1Methods of Identifying Anti-LAG-3 AgentsUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 4662US2015005235A1Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 IntegrinUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 4761US11208462B2Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the sameUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Dec 28, 2021·0 cites·20 claims
- 4861US11179441B2Ciliary neurotrophic factor receptor ligands and methods of using the sameUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Nov 23, 2021·0 cites·20 claims
- 4961US2022226435A1Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the SameUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 5059US2020318104A1Micro-screening Apparatus, Process, and ProductsUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jennifer R. Cochran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →